SWISS TAKEOVER BOARD

Current transactions

Offer

0946

PolyPeptide Group AG (2026)

Offeror: Samsung Biologics Co., Ltd., Incheon, Republik Korea

Voluntary offer
Offer initially friendly
Cash offer

Obligation to make an offer (existence/exemptions)

0952

dormakaba Holding AG (2026)

Applicant: dormakaba Holding AG
Applicant: Familie Mankel Industriebeteiligungs GmbH + Co. KGaA
Applicant: Mankel Family Office GmbH
Applicant: Kaba Familienaktionäre

(Non-)existence of a mandatory offer
0672

SHL Telemedicine Ltd. (2017)

Applicant: Nehama & Yoram Alroy Investment Ltd., Tel Aviv, Israel
Applicant: Elon Shalev, Tel Aviv, Israel

(Non-)existence of a mandatory offer

Buyback programmes

0950

TEMENOS AG (2026)

Buyback programme
Exemption in reporting procedure
Buyback on regular line
0945

UBS Group AG (2026)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0940

Geberit AG (2026)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0936

Alcon AG (2026)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0933

Amrize AG (2026)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0928

Avolta AG (2026)

Buyback programme
Exemption in reporting procedure
Buyback on regular line
0924

Swiss Re AG (2026)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0923

Novartis AG (2026)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0922

ABB Ltd (2026)

Buyback programme
Exemption in reporting procedure
Buyback on separate line
0911

TX Group AG (2025)

Buyback programme
Exemption in reporting procedure
Buyback on separate line